Product Information
TOPIRAMATE ER 100 MG SPRINK CAP is a generic product labeled by Vitruvias Therapeutics Inc., priced at $5.5959 per EA under NDC 69680017930. Its NADAC has been published 51 times since Jul 9, 2025.
Strength
100 mg/1
Manufacturer
Vitruvias Therapeutics Inc.NDC
69680017930
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
TOPIRAMATEApproval Type
Generic (ANDA)
FDA Application
ANDA215638On Market Since
4/7/2025
Pharmacological Classes
Price Statistics
The NADAC for TOPIRAMATE ER 100 MG SPRINK CAP has been published 51 times since Jul 9, 2025, and over the history we have for it it has declined 42.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $5.5959 per EA |
|---|---|
| All-time high | $9.6739 (Jul 16, 2025) |
| All-time low | $5.5959 (Jun 17, 2026) |
| 52-week high | $9.6739 |
| 52-week low | $5.5959 |
| Median price | $8.4373 |
| Average price | $7.9051 |
| Largest weekly change | -12.0% (Mar 18, 2026) |
| Weeks tracked | 51 |
| Tracking since | Jul 9, 2025 |
Generic Alternatives
The matcher finds 11 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TOPIRAMATE ER 100 MG SPRINK CAP?
The current National Average Drug Acquisition Cost (NADAC) for TOPIRAMATE ER 100 MG SPRINK CAP, manufactured by Vitruvias Therapeutics Inc., is $5.5959 per EA (NDC 69680017930), effective Jun 24, 2026.
How has the price of TOPIRAMATE ER 100 MG SPRINK CAP changed over time?
Over the history we have for it, the NADAC for TOPIRAMATE ER 100 MG SPRINK CAP has declined 42.2%. It has been tracked across 51 weekly CMS publications since Jul 9, 2025.
What are the highest and lowest recorded NADAC prices for TOPIRAMATE ER 100 MG SPRINK CAP?
Since Jul 9, 2025, the NADAC for TOPIRAMATE ER 100 MG SPRINK CAP has ranged from a low of $5.5959 (Jun 17, 2026) to a high of $9.6739 (Jul 16, 2025), with a median of $8.4373 per EA.
Are there cheaper alternatives to TOPIRAMATE ER 100 MG SPRINK CAP?
Yes. 11 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, TOPIRAMATE 100 MG TABLET, is $0.0559 per EA — about 99% below TOPIRAMATE ER 100 MG SPRINK CAP.
Who manufactures TOPIRAMATE ER 100 MG SPRINK CAP?
TOPIRAMATE ER 100 MG SPRINK CAP (NDC 69680017930) is labeled by Vitruvias Therapeutics Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification